No timeline for new late-stage prostate cancer treatment in Manitoba
September of last year, Health Canada gave a new prostate cancer treatment approval for patients with advanced metastatic cases.
It's called PLUVICTO (lutetium (177lu) vipivotide tetraxetan injection) which uses a radioactive particle to attack a certain type of cancer protein. But doctors say there are hurdles ahead for eligible patients to access the treatment, as its approval is just step one.
Prostate cancer is one of the most commonly diagnosed cancers in men. In 80 per cent of cases, the cancer cells have a surface protein called prostate-specific membrane antigen or PSMA. PSMA is the biomarker or target for PLUVICTO.
"I know that our nuclear medical physicians are extremely aware of this,” said Dr. Piotr Czaykowski, a medical oncologist at CancerCare Manitoba. “We have regular conversations with them about this. We know they're keen to try and implement this as soon as it’s something we can implement."
Czaykowski told CTV News this type of technology is already used in the province for a rare type of cancer called neuroendocrine tumour but getting PLUVICTO out to late-stage prostate cancer patients through the public system will take more time.
"Right now where this sits, is there are negotiations underway to establish a price and once that's in place then we have the opportunity to start trying to provide this," he said.
A provincial spokesperson tells CTV News, PLUVICTO has also received a positive recommendation from the Canadian Agency for Drugs and Technologies in Health (CADTH) but it still needs to undergo national negotiations through the panCanadian Pharmaceutical Alliance.
“Only after those negotiations are completed and an agreement is in place with the manufacturer, will Manitoba list the product in the oncology drug formulary,” reads the written statement.
Although it’s not available publicly, Canadians can choose to pay out of pocket for the treatment. At a private clinic in Burnaby, B.C., two patients received PLUVICTO treatments this week.
"The way we describe this is we see what we treat and we treat what we can see," said Dr. Philip Cohen, a nuclear medicine specialist and the medical director at INITIO Medical.
He said the price for the compound, whether being bought by the government or a patient, is $27,000 a dose.
"What I am hopeful for is, as more compounds will make it through the approval process, the cost will plummet and hopefully will become more affordable," said Cohen.
While optimistic for what nuclear treatments might be able to accomplish in the cancer realm, he points out another major issue that may make accessing this type of treatment difficult in Canada. A Positron Emission Tomography or PET scan is required to screen patients.
"There's probably an adequate number in Quebec but outside Quebec there's real limitations to access to pet scanners,” he said.
According to Shared Health there is only one PET scanner in Manitoba at Health Sciences Centre.
Czaykowski says while PLUVICTO is not a home run or a cure, it will be well worth offering to eligible late-stage prostate cancer patients.
"In the studies that have been done, and there was a large trial where half the patients got this therapy and the other half didn't, those who got the therapy lived about five months longer," he explained.
Adding, once there’s the science to support it, there is the potential for the agent to be used earlier during the course of treatment.
CTVNews.ca Top Stories
'They needed people inside Air Canada:' Police announce arrests in Pearson gold heist
Police say one former and one current employee of Air Canada are among the nine suspects that are facing charges in connection with the gold heist at Pearson International Airport last year.
House admonishes ArriveCan contractor in rare parliamentary show of power
MPs enacted an extraordinary, rarely used parliamentary power on Wednesday, summonsing an ArriveCan contractor to appear before the House of Commons where he was admonished publicly and forced to provide answers to the questions MPs said he'd previously evaded.
Leafs star Auston Matthews finishes season with 69 goals
Auston Matthews won't be joining the NHL's 70-goal club this season.
Trump lawyers say Stormy Daniels refused subpoena outside a Brooklyn bar, papers left 'at her feet'
Donald Trump's legal team says it tried serving Stormy Daniels a subpoena as she arrived for an event at a bar in Brooklyn last month, but the porn actor, who is expected to be a witness at the former president's criminal trial, refused to take it and walked away.
Why drivers in Eastern Canada could see big gas price spikes, and other Canadians won't
Drivers in Eastern Canada face a big increase in gas prices because of various factors, especially the higher cost of the summer blend, industry analysts say.
Doug Ford calls on Ontario Speaker to reverse Queen's Park keffiyeh ban
Ontario Premier Doug Ford is calling on Speaker Ted Arnott to reverse a ban on keffiyehs at Queen's Park, describing the move as “needlessly” divisive.
'A living nightmare': Winnipeg woman sentenced following campaign of harassment against man after online date
A Winnipeg woman was sentenced to house arrest after a single date with a man she met online culminated in her harassing him for years, and spurred false allegations which resulted in the innocent man being arrested three times.
Woman who pressured boyfriend to kill his ex in 2000s granted absences from prison
A woman who pressured her boyfriend into killing his teenage ex more than a decade ago will be allowed to leave prison for weeks at a time.
Customers disappointed after email listing $60K Tim Hortons prize sent in error
Several Tim Horton’s customers are feeling great disappointment after being told by the company that an email stating they won a boat worth nearly $60,000 was sent in error.